Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Schwab International Small-Cap Equity ETF
SCHC
$5.59B
| $9.91M | ﹤0.01% |
335,043
+509
| +0.2% | +$14.1K |
|
|
IMGN
2102
DELISTED
Immunogen Inc
IMGN
| $9.9M | ﹤0.01% |
2,151,300
+33,796
| +2% | +$144K |
|
|
IGMS
2103
DELISTED
IGM Biosciences
IGMS
| $9.89M | ﹤0.01% |
135,552
+45,692
| +51% | +$2.78M |
|
2104
Genmab
GMAB
$18B
| $9.89M | ﹤0.01% |
291,866
+734
| +0.3% | +$20K |
|
2105
Assembly Biosciences
ASMB
$526M
| $9.85M | ﹤0.01% |
35,203
+4,211
| +14% | +$982K |
|
2106
Phreesia
PHR
$710M
| $9.83M | ﹤0.01% |
347,569
-58,486
| -14% | -$1.52M |
|
|
VISN
2107
Vistance Networks Inc
VISN
$2.79B
| $9.82M | ﹤0.01% |
1,178,815
+183,575
| +18% | +$1.81M |
|
2108
Inogen
INGN
$178M
| $9.81M | ﹤0.01% |
276,361
-2,534
| -0.9% | -$107K |
|
2109
Vanguard Real Estate ETF
VNQ
$39.2B
| $9.81M | ﹤0.01% |
124,899
-216,236
| -63% | -$16.4M |
|
2110
The Greenbrier Companies
GBX
$1.54B
| $9.81M | ﹤0.01% |
431,061
-5,654
| -1% | -$110K |
|
|
TCDA
2111
DELISTED
Tricida, Inc. Common Stock
TCDA
| $9.8M | ﹤0.01% |
356,556
+72,320
| +25% | +$1.97M |
|
2112
Green Plains
GPRE
$1.15B
| $9.79M | ﹤0.01% |
958,046
+29,618
| +3% | +$218K |
|
2113
Enova International
ENVA
$6.55B
| $9.77M | ﹤0.01% |
656,739
+87,354
| +15% | +$1.21M |
|
2114
United Parks & Resorts
PRKS
$2.17B
| $9.76M | ﹤0.01% |
658,942
+20,289
| +3% | +$299K |
|
2115
Great Southern Bancorp
GSBC
$889M
| $9.76M | ﹤0.01% |
241,806
+48,572
| +25% | +$1.92M |
|
2116
Red Rock Resorts
RRR
$3.56B
| $9.76M | ﹤0.01% |
894,473
+11,679
| +1% | +$132K |
|
|
TVRD
2117
Tvardi Therapeutics
TVRD
$18.8M
| $9.72M | ﹤0.01% |
15,796
+1,065
| +7% | +$588K |
|
2118
Cloudflare
NET
$104B
| $9.72M | ﹤0.01% |
270,410
+185,684
| +219% | +$5.19M |
|
2119
CVR Energy
CVI
$3.14B
| $9.71M | ﹤0.01% |
482,931
+3,513
| +0.7% | +$70.9K |
|
2120
Abercrombie & Fitch
ANF
$4.86B
| $9.67M | ﹤0.01% |
909,000
-12,701
| -1% | -$139K |
|
2121
Griffon
GFF
$4.72B
| $9.63M | ﹤0.01% |
519,879
-635
| -0.1% | -$10.3K |
|
|
AIMT
2122
DELISTED
Aimmune Therapeutics
AIMT
| $9.61M | ﹤0.01% |
575,106
+28,080
| +5% | +$477K |
|
2123
Reynolds Consumer Products
REYN
$5.64B
| $9.61M | ﹤0.01% |
276,601
+108,498
| +65% | +$3.54M |
|
2124
Varex Imaging
VREX
$522M
| $9.59M | ﹤0.01% |
633,070
+136,330
| +27% | +$2.75M |
|
2125
Calix
CALX
$2.42B
| $9.58M | ﹤0.01% |
642,781
+79,279
| +14% | +$910K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.